Speaker illustration

Doctor Anna Moiseeva

Institute of Cardiology, Chisinau (Moldova (Republic of))

Comparative evaluation of renal denervation versus pharmacological treatment on diastolic function in patients with resistant hypertension: three years follow-up

Event: ESC Congress 2023

Topic: Device Treatment and Intervention

Session: Drugs and devices in hypertension

Thumbnail

Impact of renal denervation treatment on NT-proBNP level and Six-Minute Walk Test in patients with resistant hypertension and heart failure with preserved ejection fraction

Event: Heart Failure 2023

Topic: Devices for Autonomic Modulation

Session: ePosters in chronic heart failure - treatment 3

Thumbnail

Long-term antihypertensive effect of renal denervation in resistant hypertension: three years follow-up

Event: ESC Congress 2022

Topic: Device Treatment and Intervention

Session: Hypertension - Treatment from pharmacotherapy to device and intervention

Thumbnail

The impact of renal denervation on diastolic function in patients with resistant hypertension and heart failure with preserved ejection fraction: one year follow-up

Event: Heart Failure 2022

Topic: Hypertension, Other

Session: Modern technologies in heart failure

Thumbnail

Modulation of sympathetic nervous system activity through various therapeutic approaches in patients with resistant hypertension and heart failure with preserved ejection fraction

Event: ESC Preventive Cardiology 2022

Topic: Multidisciplinary Interventions

Session: ePosters

Thumbnail

The effectiveness of renal denervation performed with various types of catheters on blood pressure values in patients with resistant hypertension

Event: Heart Failure 2021

Topic: Hypertension, Other

Session: ePoster session

Thumbnail

The impact of renal denervation treatment on left ventricular remodeling in patients with resistant hypertension

Event: ESC Preventive Cardiology 2021

Topic: Device Treatment and Intervention

Session: ePosters

Thumbnail

Sympathetic renal denervation treatment in resistant hypertension: one-year follow-up

Event: ESC Congress 2020

Topic: Device Treatment and Intervention

Session: Devices in Hypertension

Thumbnail

The effects of long-term treatment with sympathetic nervous system blockers on diastolic function in patients with resistant hypertension and heart failure with preserved ejection fraction

Event: Heart Failure 2019

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Thumbnail

Does metabolic syndrome influence right ventricular diastolic function in patients with preserved left ventricular systolic function?

Event: Heart Failure 2019

Topic: Imaging

Session: Chronic Heart Failure – Diagnostic Methods

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb